# Glimepiride 3 mg

NDC: 72336-641
Generic name: Glimepiride
Labeler / Manufacturer: Lifsa Drugs LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240820

FDA application: ANDA091220

## Active ingredients

- GLIMEPIRIDE: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72336-641"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72336-641
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51157849-7990-4a8b-ae50-eda1baf93cfa